1. Home
  2. ETS vs KALA Comparison

ETS vs KALA Comparison

Compare ETS & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ETS

Elite Express Holding Inc.

HOLD

Current Price

$1.61

Market Cap

12.0M

Sector

Industrials

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.54

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETS
KALA
Founded
2020
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
13.3M
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
ETS
KALA
Price
$1.61
$0.54
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$31.50
AVG Volume (30 Days)
393.4K
361.0K
Earning Date
04-13-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
67.39
EPS
N/A
N/A
Revenue
$2,665,948.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.57
N/A
52 Week Low
$0.39
$0.07
52 Week High
$1.55
$20.58

Technical Indicators

Market Signals
Indicator
ETS
KALA
Relative Strength Index (RSI) 76.21 34.86
Support Level $0.47 $0.54
Resistance Level N/A $0.72
Average True Range (ATR) 0.15 0.08
MACD 0.07 0.01
Stochastic Oscillator 99.83 14.43

Price Performance

Historical Comparison
ETS
KALA

About ETS Elite Express Holding Inc.

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: